Skip to content

Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&3

The Prevalence and Treatment of Sleep Disorders in Lung Transplant Recipients With BOS 2 & 3 and the Influence on Quality of Life and Daytime Activity.

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02109237
Enrollment
0
Registered
2014-04-09
Start date
2014-05-31
Completion date
2020-05-31
Last updated
2020-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bronchiolitis Obliterans, Sleep Disordered Breathing Central

Keywords

Lung transplantation, Bronchiolitis obliterans

Brief summary

This study is to determine whether sleep disorders contribute to impaired quality of life and mobility in patients with Bronchiolitis Obliterans syndrome and whether non invasive positive airways pressure ventilation can improve sleep, quality of life and mobility in this patient group.

Detailed description

Patients with Bronchiolitis Obliterans syndrome (BOS) 2 & 3 (25) will be matched 1:2 BOS 0 patients with similar demographics such as age, gender, BMI, time post transplant and renal dysfunction.Patients fitting inclusion/exclusion criteria once they have given informed consent will complete questionnaires on quality of life (QOL), any sleep issues they may have and be assessed by a doctor. Data from standard blood tests, respiratory function tests and physio assessments of daytime activity, mobility and muscle strength will be collected. All participants will undergo an overnight sleep study. If a sleep disorder is identified the participant will be offered appropriate treatment. All assessments with the exception of the sleep study will be repeated at 6 and 12 months post sleep study.

Interventions

PROCEDUREAssessment of sleep disorders and treatment if required

Assessment of sleep disorders and treatment if required

Sponsors

The Prince Charles Hospital
Lead SponsorOTHER_GOV

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who are post lung, heart lung and heart lung liver transplant with bronchiolitis obliterans 2 & 3 * Comparative group -Patients who are post lung, heart lung and heart lung liver transplant with bronchiolitis obliterans 0 * Identified possible sleep related disorder

Exclusion criteria

* Subjects who do not provide informed consent * Subjects unable to understand the study and related procedures * Patients with a life expectancy of less than 6 months

Design outcomes

Primary

MeasureTime frameDescription
To Measure Prevalence of sleep disorders in Bronchiolitis Obliterans 2&3 patients12 monthsUsing level one laboratory based polysomnograph

Secondary

MeasureTime frameDescription
Quality of life assessment using Rand SF36 standard surveyBaseline, 6 and 12 months after sleep studyParticipants will complete Rand SF36 standard survey for Quality of life. This will be completed at baseline visit and at 6 and 12 months post sleep study

Other

MeasureTime frameDescription
Assessment of daytime activity, mobility and muscle strengthBaseline, 6 and 12 months post sleep studyAs part of standard care transplant patients are assessed for daytime activity, mobility and muscle strength every 6months this data will be used to assess any changes post treatment for sleep disorders
Lung function assessmentBaseline, 6 and 12 months post sleep studyAssessment of lung function to determine any variation post treatment for sleep disorder.

Countries

Australia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026